Zealand Pharma Shares Tumble After Weight-Loss Drug Trial Discontinuations

Zealand Pharma's shares fell significantly after the company announced that a fifth of users discontinued its weight-loss drug during trials due to gastrointestinal issues.

8 Jun, 08:44 — 8 Jun, 08:44

Post Share

Sources

Showing 1 of 1 sources

marketwatchMostly Factual1h ago

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial

The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.

By Steve Goldstein

Read full article →

PERSPECTA

PERSPECTA

Zealand Pharma Shares Tumble After Weight-Loss Drug Trial Discontinuations

Sources

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Agrova Baltics Launches €30 Million Investment Program in Alūksne

Nigerian Telcos Dispute NBS Report on Excluded Domestic Spending

ING becomes first major Dutch bank to use AI in nonstandard mortgage applications

PERSPECTA